Genetic modification of T lymphocytes for adoptive immunotherapy

Claudia Rossig, Malcolm K. Brenner

Research output: Contribution to journalReview article

66 Scopus citations

Abstract

Adoptive transfer of T lymphocytes is a promising therapy for malignancies-particularly of the hemopoietic system-and for otherwise intractable viral diseases. Efforts to broaden the approach have been limited by the physiology of the T cells themselves and by a range of immune evasion mechanisms developed by tumor cells. In this review we show how genetic modification of T cells is being used preclinically and in patients to overcome these limitations, by incorporation of novel receptors, resistance mechanisms, and control genes. We also discuss how the increasing safety and effectiveness of gene transfer technologies will lead to an increase in the use of gene-modified T cells for the treatment of a wider range of disorders.

Original languageEnglish (US)
Pages (from-to)5-18
Number of pages14
JournalMolecular Therapy
Volume10
Issue number1
DOIs
StatePublished - Jul 2004

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Pharmacology
  • Drug Discovery

Fingerprint Dive into the research topics of 'Genetic modification of T lymphocytes for adoptive immunotherapy'. Together they form a unique fingerprint.

Cite this